ELI LILLY & Co (LLY) · Insider trading
What ELI LILLY's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$78.39B
5 insiders, 0% under a plan
Net, 12 months
−$78.39B
bought less sold
Latest filing
2026-09-22
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Lilly Endowment IncOther | – | $81.96B | 470 | 2026-05-06 | 91,883,358 |
| Jonsson PatrikEVP & President, LLY Int'l | – | $7.64M | 1 | 2026-08-17 | 54,147 |
| Zakrowski Donald ASVP, Finance, & CAO | – | $6.37M | 6 | 2026-08-10 | 1,526 |
| Hakim AnatEVP, GC & Secretary | – | $5.95M | 1 | 2026-08-07 | – |
| Skovronsky DanielEVP, CSO & Pres. LRL & LLY Imm | $634,410 | $4.32M | 4 | 2025-08-12 | 137,660 |
| Yuffa IlyaEVP&Pres, LLY USA&Global Capab | – | $4.60M | 3 | 2026-06-10 | 29,804 |
| Ricks David ADirector, President, Chair, and CEO | $1.05M | – | 1 | 2025-08-12 | 546,601 |
| Fyrwald J ErikDirector | $1.01M | – | 2 | 2025-08-12 | 73,699 |
| Van Naarden JacobEVP & Pres., Lilly Oncology | $647,360 | – | 1 | 2025-08-13 | 20,562 |
| Alvarez RalphDirector | $500,470 | – | 1 | 2025-08-13 | – |
| Montarce LucasEVP & CFO | $494,630 | – | 1 | 2025-08-15 | 14,685 |
| Jackson JamereDirector | $127,912 | – | 1 | 2025-08-08 | 9,402 |
| Sulzberger GabrielleDirector | $75,018 | – | 1 | 2025-08-12 | 2,703 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-17 | Jonsson PatrikEVP & President, LLY Int'l | Saleplan | 6,500 | 1175.10 | $7.64M | 54,147 | Form 4 |
| 2026-08-10 | Zakrowski Donald ASVP, Finance, & CAO | Saleplan | 2,000 | 1185.01 | $2.37M | 1,526 | Form 4 |
| 2026-08-07 | Hakim AnatEVP, GC & Secretary | Saleplanindirect | 5,000 | 1190.00 | $5.95M | 11,875 | Form 4 |
| 2026-06-10 | Yuffa IlyaEVP&Pres, LLY USA&Global Capab | Saleplan | 2,500 | 1150.77 | $2.88M | 29,804 | Form 4 |
| 2026-05-06 | Lilly Endowment IncOther | Sale | 13,620 | 995.23 | $13.56M | 91,883,358 | Form 4 |
| 2026-05-06 | Lilly Endowment IncOther | Sale | 2,208 | 996.18 | $2.20M | 91,881,150 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 895 | 1085.11 | $971,173 | 92,188,231 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 7,684 | 1086.75 | $8.35M | 92,180,547 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 1,070 | 1087.80 | $1.16M | 92,179,477 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 930 | 1088.97 | $1.01M | 92,178,547 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 3,575 | 1090.18 | $3.90M | 92,174,972 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 1,224 | 1091.05 | $1.34M | 92,173,748 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 1,072 | 1092.56 | $1.17M | 92,172,676 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 1,322 | 1093.58 | $1.45M | 92,171,354 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 420 | 1094.70 | $459,774 | 92,170,934 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 475 | 1095.74 | $520,476 | 92,170,459 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 6,408 | 1097.41 | $7.03M | 92,164,051 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 9,573 | 1098.55 | $10.52M | 92,154,478 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 20,447 | 1099.36 | $22.48M | 92,134,031 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 14,937 | 1100.46 | $16.44M | 92,119,094 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 20,668 | 1101.42 | $22.76M | 92,098,426 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 34,434 | 1102.41 | $37.96M | 92,063,992 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 40,956 | 1103.31 | $45.19M | 92,023,036 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 21,042 | 1104.40 | $23.24M | 92,001,994 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 24,362 | 1105.46 | $26.93M | 91,977,632 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 13,701 | 1106.42 | $15.16M | 91,963,931 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 16,650 | 1107.37 | $18.44M | 91,947,281 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 13,247 | 1108.42 | $14.68M | 91,934,034 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 8,513 | 1109.32 | $9.44M | 91,925,521 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 3,464 | 1110.37 | $3.85M | 91,922,057 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 2,085 | 1111.21 | $2.32M | 91,919,972 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 4,652 | 1112.43 | $5.18M | 91,915,320 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 9,053 | 1113.77 | $10.08M | 91,906,267 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 4,342 | 1114.37 | $4.84M | 91,901,925 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 2,210 | 1115.76 | $2.47M | 91,899,715 | Form 4 |
| 2026-01-07 | Lilly Endowment Inc10% owner | Sale | 2,737 | 1116.69 | $3.06M | 91,896,978 | Form 4 |
| 2026-01-05 | Lilly Endowment Inc10% owner | Sale | 1,390 | 1085.01 | $1.51M | 92,189,126 | Form 4 |
| 2025-12-29 | Lilly Endowment Inc10% owner | Sale | 3,593 | 1085.04 | $3.90M | 92,190,516 | Form 4 |
| 2025-12-24 | Lilly Endowment Inc10% owner | Sale | 2,629 | 1085.17 | $2.85M | 92,194,109 | Form 4 |
| 2025-12-23 | Lilly Endowment Inc10% owner | Sale | 240 | 1085.04 | $260,410 | 92,196,738 | Form 4 |
453 more
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 2,481 | 1073.74 | $2.66M | 92,357,190 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 882 | 1076.00 | $949,032 | 92,356,308 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 800 | 1077.99 | $862,392 | 92,355,508 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 1,260 | 1079.37 | $1.36M | 92,354,248 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 651 | 1080.73 | $703,555 | 92,353,597 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 1,606 | 1081.90 | $1.74M | 92,351,991 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 160 | 1082.93 | $173,269 | 92,351,831 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 3,069 | 1084.70 | $3.33M | 92,348,762 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 5,604 | 1086.07 | $6.09M | 92,343,158 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 6,508 | 1086.94 | $7.07M | 92,336,650 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 5,589 | 1087.97 | $6.08M | 92,331,061 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 5,284 | 1088.91 | $5.75M | 92,325,777 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 1,907 | 1089.85 | $2.08M | 92,323,870 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 5,927 | 1091.12 | $6.47M | 92,317,943 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 18,254 | 1092.06 | $19.93M | 92,299,689 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 9,050 | 1093.16 | $9.89M | 92,290,639 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 6,246 | 1094.03 | $6.83M | 92,284,393 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 2,083 | 1094.79 | $2.28M | 92,282,310 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 1,061 | 1096.33 | $1.16M | 92,281,249 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 4,198 | 1097.44 | $4.61M | 92,277,051 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 4,639 | 1098.32 | $5.10M | 92,272,412 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 6,545 | 1099.49 | $7.20M | 92,265,867 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 8,527 | 1100.34 | $9.38M | 92,257,340 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 11,854 | 1101.45 | $13.06M | 92,245,486 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 7,456 | 1102.35 | $8.22M | 92,238,030 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 6,274 | 1103.58 | $6.92M | 92,231,756 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 5,196 | 1104.41 | $5.74M | 92,226,560 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 2,494 | 1105.32 | $2.76M | 92,224,066 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 3,662 | 1106.57 | $4.05M | 92,220,404 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 7,794 | 1107.48 | $8.63M | 92,212,610 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 5,043 | 1108.71 | $5.59M | 92,207,567 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 9,249 | 1109.45 | $10.26M | 92,198,318 | Form 4 |
| 2025-11-25 | Lilly Endowment Inc10% owner | Sale | 1,340 | 1110.53 | $1.49M | 92,196,978 | Form 4 |
| 2025-11-24 | Lilly Endowment Inc10% owner | Sale | 120,016 | 1068.18 | $128.20M | 92,381,962 | Form 4 |
| 2025-11-24 | Lilly Endowment Inc10% owner | Sale | 14,105 | 1069.48 | $15.09M | 92,367,857 | Form 4 |
| 2025-11-24 | Lilly Endowment Inc10% owner | Sale | 2,778 | 1070.35 | $2.97M | 92,365,079 | Form 4 |
| 2025-11-24 | Lilly Endowment Inc10% owner | Sale | 1,710 | 1071.37 | $1.83M | 92,363,369 | Form 4 |
| 2025-11-24 | Lilly Endowment Inc10% owner | Sale | 744 | 1072.78 | $798,148 | 92,362,625 | Form 4 |
| 2025-11-24 | Lilly Endowment Inc10% owner | Sale | 2,954 | 1073.60 | $3.17M | 92,359,671 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 9,871 | 1050.27 | $10.37M | 92,597,433 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 5,506 | 1051.48 | $5.79M | 92,591,927 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 2,885 | 1052.36 | $3.04M | 92,589,042 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 1,987 | 1053.46 | $2.09M | 92,587,055 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 1,629 | 1054.42 | $1.72M | 92,585,426 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 2,495 | 1055.45 | $2.63M | 92,582,931 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 1,546 | 1056.40 | $1.63M | 92,581,385 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 5,064 | 1057.58 | $5.36M | 92,576,321 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 9,729 | 1058.46 | $10.30M | 92,566,592 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 23,916 | 1059.66 | $25.34M | 92,542,676 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 7,582 | 1060.53 | $8.04M | 92,535,094 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 10,492 | 1061.56 | $11.14M | 92,524,602 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 9,051 | 1062.52 | $9.62M | 92,515,551 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 8,576 | 1063.57 | $9.12M | 92,506,975 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 3,378 | 1064.43 | $3.60M | 92,503,597 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 1,459 | 1065.57 | $1.55M | 92,502,138 | Form 4 |
| 2025-11-21 | Lilly Endowment Inc10% owner | Sale | 160 | 1066.15 | $170,584 | 92,501,978 | Form 4 |
| 2025-11-20 | Lilly Endowment Inc10% owner | Sale | 16,845 | 1050.36 | $17.69M | 92,627,607 | Form 4 |
| 2025-11-20 | Lilly Endowment Inc10% owner | Sale | 6,701 | 1051.37 | $7.05M | 92,620,906 | Form 4 |
| 2025-11-20 | Lilly Endowment Inc10% owner | Sale | 6,047 | 1052.55 | $6.36M | 92,614,859 | Form 4 |
| 2025-11-20 | Lilly Endowment Inc10% owner | Sale | 3,702 | 1053.52 | $3.90M | 92,611,157 | Form 4 |
| 2025-11-20 | Lilly Endowment Inc10% owner | Sale | 3,188 | 1054.51 | $3.36M | 92,607,969 | Form 4 |
| 2025-11-20 | Lilly Endowment Inc10% owner | Sale | 665 | 1055.39 | $701,834 | 92,607,304 | Form 4 |
| 2025-11-19 | Lilly Endowment Inc10% owner | Sale | 96,516 | 1050.21 | $101.36M | 92,715,462 | Form 4 |
| 2025-11-19 | Lilly Endowment Inc10% owner | Sale | 28,768 | 1051.43 | $30.25M | 92,686,694 | Form 4 |
| 2025-11-19 | Lilly Endowment Inc10% owner | Sale | 21,107 | 1052.54 | $22.22M | 92,665,587 | Form 4 |
| 2025-11-19 | Lilly Endowment Inc10% owner | Sale | 13,820 | 1053.47 | $14.56M | 92,651,767 | Form 4 |
| 2025-11-19 | Lilly Endowment Inc10% owner | Sale | 6,109 | 1054.48 | $6.44M | 92,645,658 | Form 4 |
| 2025-11-19 | Lilly Endowment Inc10% owner | Sale | 1,206 | 1055.08 | $1.27M | 92,644,452 | Form 4 |
| 2025-11-18 | Lilly Endowment Inc10% owner | Sale | 4,304 | 1030.32 | $4.43M | 92,867,887 | Form 4 |
| 2025-11-18 | Lilly Endowment Inc10% owner | Sale | 1,605 | 1031.41 | $1.66M | 92,866,282 | Form 4 |
| 2025-11-18 | Lilly Endowment Inc10% owner | Sale | 7,208 | 1032.64 | $7.44M | 92,859,074 | Form 4 |
| 2025-11-18 | Lilly Endowment Inc10% owner | Sale | 6,380 | 1033.50 | $6.59M | 92,852,694 | Form 4 |
| 2025-11-18 | Lilly Endowment Inc10% owner | Sale | 12,198 | 1034.65 | $12.62M | 92,840,496 | Form 4 |
| 2025-11-18 | Lilly Endowment Inc10% owner | Sale | 13,097 | 1035.50 | $13.56M | 92,827,399 | Form 4 |
| 2025-11-18 | Lilly Endowment Inc10% owner | Sale | 8,067 | 1036.58 | $8.36M | 92,819,332 | Form 4 |
| 2025-11-18 | Lilly Endowment Inc10% owner | Sale | 2,424 | 1037.38 | $2.51M | 92,816,908 | Form 4 |
| 2025-11-18 | Lilly Endowment Inc10% owner | Sale | 3,950 | 1038.48 | $4.10M | 92,812,958 | Form 4 |
| 2025-11-18 | Lilly Endowment Inc10% owner | Sale | 980 | 1039.61 | $1.02M | 92,811,978 | Form 4 |
| 2025-11-17 | Lilly Endowment Inc10% owner | Sale | 7,789 | 1030.45 | $8.03M | 92,874,288 | Form 4 |
| 2025-11-17 | Lilly Endowment Inc10% owner | Sale | 2,097 | 1031.53 | $2.16M | 92,872,191 | Form 4 |
| 2025-11-14 | Lilly Endowment Inc10% owner | Sale | 103,871 | 1030.31 | $107.02M | 92,956,501 | Form 4 |
| 2025-11-14 | Lilly Endowment Inc10% owner | Sale | 55,908 | 1031414.00 | $57.66B | 92,900,593 | Form 4 |
| 2025-11-14 | Lilly Endowment Inc10% owner | Sale | 17,567 | 1032319.00 | $18.13B | 92,883,026 | Form 4 |
| 2025-11-14 | Lilly Endowment Inc10% owner | Sale | 949 | 1033.16 | $980,469 | 92,882,077 | Form 4 |
| 2025-11-13 | Lilly Endowment Inc10% owner | Sale | 45,246 | 1030.21 | $46.61M | 93,061,732 | Form 4 |
| 2025-11-13 | Lilly Endowment Inc10% owner | Sale | 1,360 | 1031.78 | $1.40M | 93,060,372 | Form 4 |
| 2025-11-13 | Zakrowski Donald ASVP, Finance, & CAO | Saleplan | 1,000 | 1010.50 | $1.01M | 2,840 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 828 | 1001.93 | $829,598 | 93,411,150 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 7,585 | 1003.12 | $7.61M | 93,403,565 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 22,131 | 1004.10 | $22.22M | 93,381,434 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 23,568 | 1004.97 | $23.69M | 93,357,866 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 23,863 | 1006.02 | $24.01M | 93,334,003 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 16,383 | 1007.10 | $16.50M | 93,317,620 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 8,913 | 1007.97 | $8.98M | 93,308,707 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 17,985 | 1009.00 | $18.15M | 93,290,722 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 20,000 | 1009.99 | $20.20M | 93,270,722 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 19,892 | 1011.18 | $20.11M | 93,250,830 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 21,559 | 1011.96 | $21.82M | 93,229,271 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 16,749 | 1012.94 | $16.97M | 93,212,522 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 11,638 | 1014.17 | $11.80M | 93,200,884 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 16,274 | 1015.16 | $16.52M | 93,184,610 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 13,415 | 1016.01 | $13.63M | 93,171,195 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 7,188 | 1017.16 | $7.31M | 93,164,007 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 47,073 | 1018.02 | $47.92M | 93,116,934 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 7,833 | 1018.83 | $7.98M | 93,109,101 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 1,281 | 1019.92 | $1.31M | 93,107,820 | Form 4 |
| 2025-11-12 | Lilly Endowment Inc10% owner | Sale | 842 | 1021.07 | $859,741 | 93,106,978 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 11,819 | 972.27 | $11.49M | 93,683,290 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 11,998 | 973.48 | $11.68M | 93,671,292 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 10,114 | 974.47 | $9.86M | 93,661,178 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 8,996 | 975.46 | $8.78M | 93,652,182 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 5,759 | 976.49 | $5.62M | 93,646,423 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 4,680 | 977.44 | $4.57M | 93,641,743 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 4,433 | 978.69 | $4.34M | 93,637,310 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 3,555 | 979.65 | $3.48M | 93,633,755 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 2,068 | 980.54 | $2.03M | 93,631,687 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 2,211 | 981.85 | $2.17M | 93,629,476 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 7,503 | 983.14 | $7.38M | 93,621,973 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 11,066 | 984.04 | $10.89M | 93,610,907 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 8,877 | 985.26 | $8.75M | 93,602,030 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 30,633 | 986.18 | $30.21M | 93,571,397 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 13,678 | 987.18 | $13.50M | 93,557,719 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 4,473 | 987.91 | $4.42M | 93,553,246 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 22,127 | 989.18 | $21.89M | 93,531,119 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 33,154 | 990.19 | $32.83M | 93,497,965 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 26,761 | 991.01 | $26.52M | 93,471,204 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 9,369 | 992.01 | $9.29M | 93,461,835 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 9,879 | 993.10 | $9.81M | 93,451,956 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 5,022 | 994.12 | $4.99M | 93,446,934 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 4,664 | 995.25 | $4.64M | 93,442,270 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 12,039 | 996.38 | $12.00M | 93,430,231 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 9,387 | 997.06 | $9.36M | 93,420,844 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 5,482 | 998.29 | $5.47M | 93,415,362 | Form 4 |
| 2025-11-11 | Lilly Endowment Inc10% owner | Sale | 3,384 | 999.09 | $3.38M | 93,411,978 | Form 4 |
| 2025-11-10 | Lilly Endowment Inc10% owner | Sale | 12,864 | 972.17 | $12.51M | 93,699,114 | Form 4 |
| 2025-11-10 | Lilly Endowment Inc10% owner | Sale | 3,887 | 973.63 | $3.78M | 93,695,227 | Form 4 |
| 2025-11-10 | Lilly Endowment Inc10% owner | Sale | 118 | 974.09 | $114,943 | 93,695,109 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 270 | 911.01 | $245,973 | 93,931,182 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 620 | 913.78 | $566,544 | 93,930,562 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 550 | 915.33 | $503,432 | 93,930,012 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 230 | 917.26 | $210,970 | 93,929,782 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 160 | 918.12 | $146,899 | 93,929,622 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 2,090 | 921.50 | $1.93M | 93,927,532 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 4,434 | 922.42 | $4.09M | 93,923,098 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 2,635 | 923.46 | $2.43M | 93,920,463 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 550 | 924.35 | $508,392 | 93,919,913 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 31,016 | 925.87 | $28.72M | 93,888,897 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 8,409 | 927.12 | $7.80M | 93,880,488 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 4,457 | 928.20 | $4.14M | 93,876,031 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 15,230 | 929.42 | $14.16M | 93,860,801 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 5,528 | 930.22 | $5.14M | 93,855,273 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 10,938 | 931.25 | $10.19M | 93,844,335 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 12,924 | 932.27 | $12.05M | 93,831,411 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 6,642 | 933.29 | $6.20M | 93,824,769 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 9,209 | 934.21 | $8.60M | 93,815,560 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 6,386 | 935.26 | $5.97M | 93,809,174 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 5,292 | 936.57 | $4.96M | 93,803,882 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 3,731 | 937.42 | $3.50M | 93,800,151 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 3,388 | 938.43 | $3.18M | 93,796,763 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 2,790 | 939.54 | $2.62M | 93,793,973 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 3,966 | 940.62 | $3.73M | 93,790,007 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 2,759 | 941.36 | $2.60M | 93,787,248 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 1,657 | 942.31 | $1.56M | 93,785,591 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 3,820 | 943.71 | $3.60M | 93,781,771 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 12,581 | 944.68 | $11.89M | 93,769,190 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 13,007 | 945.62 | $12.30M | 93,756,183 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 3,773 | 946.40 | $3.57M | 93,752,410 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 1,909 | 947.63 | $1.81M | 93,750,501 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 5,617 | 948.82 | $5.33M | 93,744,884 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 4,495 | 949.82 | $4.27M | 93,740,389 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 2,010 | 950.94 | $1.91M | 93,738,379 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 10,200 | 952.00 | $9.71M | 93,728,179 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 10,392 | 952.89 | $9.90M | 93,717,787 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 4,699 | 953.66 | $4.48M | 93,713,088 | Form 4 |
| 2025-11-05 | Lilly Endowment Inc10% owner | Sale | 1,110 | 954.95 | $1.06M | 93,711,978 | Form 4 |
| 2025-11-04 | Lilly Endowment Inc10% owner | Sale | 526 | 910.72 | $479,039 | 93,931,452 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 25,996 | 877.40 | $22.81M | 94,205,982 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 18,815 | 878.36 | $16.53M | 94,187,167 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 6,125 | 879.36 | $5.39M | 94,181,042 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 10,549 | 880.45 | $9.29M | 94,170,493 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 6,373 | 881.46 | $5.62M | 94,164,120 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 4,226 | 882.32 | $3.73M | 94,159,894 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 10,681 | 883.75 | $9.44M | 94,149,213 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 26,340 | 884.67 | $23.30M | 94,122,873 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 21,884 | 885.56 | $19.38M | 94,100,989 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 3,038 | 886.29 | $2.69M | 94,097,951 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 4,081 | 888.14 | $3.62M | 94,093,870 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 2,452 | 888.96 | $2.18M | 94,091,418 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 14,867 | 890.20 | $13.23M | 94,076,551 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 15,508 | 891.17 | $13.82M | 94,061,043 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 17,299 | 891.97 | $15.43M | 94,043,744 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 4,246 | 893.35 | $3.79M | 94,039,498 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 17,537 | 894.33 | $15.68M | 94,021,961 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 17,639 | 895.16 | $15.79M | 94,004,322 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 29,709 | 896.15 | $26.62M | 93,974,613 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 11,842 | 897.20 | $10.62M | 93,962,771 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 19,295 | 898.20 | $17.33M | 93,943,476 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 5,391 | 899.18 | $4.85M | 93,938,085 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 4,474 | 900.02 | $4.03M | 93,933,611 | Form 4 |
| 2025-11-03 | Lilly Endowment Inc10% owner | Sale | 1,633 | 900.79 | $1.47M | 93,931,978 | Form 4 |
| 2025-10-31 | Lilly Endowment Inc10% owner | Sale | 197,814 | 862.63 | $170.64M | 94,335,506 | Form 4 |
| 2025-10-31 | Lilly Endowment Inc10% owner | Sale | 54,191 | 863.42 | $46.79M | 94,281,315 | Form 4 |
| 2025-10-31 | Lilly Endowment Inc10% owner | Sale | 15,671 | 864.53 | $13.55M | 94,265,644 | Form 4 |
| 2025-10-31 | Lilly Endowment Inc10% owner | Sale | 10,356 | 865.60 | $8.96M | 94,255,288 | Form 4 |
| 2025-10-31 | Lilly Endowment Inc10% owner | Sale | 10,358 | 866.55 | $8.98M | 94,244,930 | Form 4 |
| 2025-10-31 | Lilly Endowment Inc10% owner | Sale | 4,602 | 867.54 | $3.99M | 94,240,328 | Form 4 |
| 2025-10-31 | Lilly Endowment Inc10% owner | Sale | 5,440 | 868.44 | $4.72M | 94,234,888 | Form 4 |
| 2025-10-31 | Lilly Endowment Inc10% owner | Sale | 2,910 | 869.47 | $2.53M | 94,231,978 | Form 4 |
| 2025-10-10 | Lilly Endowment Inc10% owner | Sale | 468 | 862.34 | $403,575 | 94,536,510 | Form 4 |
| 2025-10-10 | Lilly Endowment Inc10% owner | Sale | 3,190 | 863.37 | $2.75M | 94,533,320 | Form 4 |
| 2025-10-09 | Lilly Endowment Inc10% owner | Sale | 600 | 848.63 | $509,178 | 94,546,980 | Form 4 |
| 2025-10-09 | Lilly Endowment Inc10% owner | Sale | 400 | 850.05 | $340,020 | 94,546,580 | Form 4 |
| 2025-10-09 | Lilly Endowment Inc10% owner | Sale | 3,375 | 851.58 | $2.87M | 94,543,205 | Form 4 |
| 2025-10-09 | Lilly Endowment Inc10% owner | Sale | 2,472 | 852.21 | $2.11M | 94,540,733 | Form 4 |
| 2025-10-09 | Lilly Endowment Inc10% owner | Sale | 1,247 | 853.20 | $1.06M | 94,539,486 | Form 4 |
| 2025-10-09 | Lilly Endowment Inc10% owner | Sale | 1,473 | 854.61 | $1.26M | 94,538,013 | Form 4 |
| 2025-10-09 | Lilly Endowment Inc10% owner | Sale | 835 | 854.96 | $713,892 | 94,537,178 | Form 4 |
| 2025-10-09 | Lilly Endowment Inc10% owner | Sale | 200 | 857.26 | $171,452 | 94,536,978 | Form 4 |
| 2025-10-08 | Lilly Endowment Inc10% owner | Sale | 18,132 | 848.46 | $15.38M | 94,630,868 | Form 4 |
| 2025-10-08 | Lilly Endowment Inc10% owner | Sale | 25,296 | 849.60 | $21.49M | 94,605,572 | Form 4 |
| 2025-10-08 | Lilly Endowment Inc10% owner | Sale | 36,114 | 850.52 | $30.72M | 94,569,458 | Form 4 |
| 2025-10-08 | Lilly Endowment Inc10% owner | Sale | 13,624 | 851.40 | $11.60M | 94,555,834 | Form 4 |
| 2025-10-08 | Lilly Endowment Inc10% owner | Sale | 3,227 | 852.36 | $2.75M | 94,552,607 | Form 4 |
| 2025-10-08 | Lilly Endowment Inc10% owner | Sale | 3,881 | 853.85 | $3.31M | 94,548,726 | Form 4 |
| 2025-10-08 | Lilly Endowment Inc10% owner | Sale | 946 | 854.64 | $808,489 | 94,547,780 | Form 4 |
| 2025-10-08 | Lilly Endowment Inc10% owner | Sale | 200 | 856.00 | $171,200 | 94,547,580 | Form 4 |
| 2025-10-07 | Lilly Endowment Inc10% owner | Sale | 26,795 | 848.01 | $22.72M | 94,649,000 | Form 4 |
| 2025-10-06 | Lilly Endowment Inc10% owner | Sale | 63,849 | 848.30 | $54.16M | 94,773,129 | Form 4 |
| 2025-10-06 | Lilly Endowment Inc10% owner | Sale | 28,063 | 849.44 | $23.84M | 94,745,066 | Form 4 |
| 2025-10-06 | Lilly Endowment Inc10% owner | Sale | 22,960 | 850.65 | $19.53M | 94,722,106 | Form 4 |
| 2025-10-06 | Lilly Endowment Inc10% owner | Sale | 12,180 | 851.58 | $10.37M | 94,709,926 | Form 4 |
| 2025-10-06 | Lilly Endowment Inc10% owner | Sale | 9,767 | 852.67 | $8.33M | 94,700,159 | Form 4 |
| 2025-10-06 | Lilly Endowment Inc10% owner | Sale | 14,822 | 853.65 | $12.65M | 94,685,337 | Form 4 |
| 2025-10-06 | Lilly Endowment Inc10% owner | Sale | 7,143 | 854.54 | $6.10M | 94,678,194 | Form 4 |
| 2025-10-06 | Lilly Endowment Inc10% owner | Sale | 2,399 | 855.71 | $2.05M | 94,675,795 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 4,286 | 821.42 | $3.52M | 95,025,096 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 1,558 | 822.42 | $1.28M | 95,023,538 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 2,644 | 823.65 | $2.18M | 95,020,894 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 9,823 | 824.68 | $8.10M | 95,011,071 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 2,804 | 825.53 | $2.31M | 95,008,267 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 4,150 | 826.74 | $3.43M | 95,004,117 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 952 | 827.41 | $787,694 | 95,003,165 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 200 | 828.50 | $165,700 | 95,002,965 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 872 | 829.86 | $723,638 | 95,002,093 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 300 | 831.05 | $249,315 | 95,001,793 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 2,204 | 833.83 | $1.84M | 94,999,589 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 3,509 | 834.76 | $2.93M | 94,996,080 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 8,203 | 835.77 | $6.86M | 94,987,877 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 16,792 | 836.86 | $14.05M | 94,971,085 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 22,843 | 837.78 | $19.14M | 94,948,242 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 7,894 | 838.86 | $6.62M | 94,940,348 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 31,102 | 839.94 | $26.12M | 94,909,246 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 24,495 | 840.74 | $20.59M | 94,884,751 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 11,316 | 841.70 | $9.52M | 94,873,435 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 10,040 | 842.95 | $8.46M | 94,863,395 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 7,114 | 843.64 | $6.00M | 94,856,281 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 10,135 | 845.07 | $8.56M | 94,846,146 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 3,893 | 845.82 | $3.29M | 94,842,253 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 4,870 | 847.03 | $4.13M | 94,837,383 | Form 4 |
| 2025-10-03 | Lilly Endowment Inc10% owner | Sale | 405 | 847.60 | $343,278 | 94,836,978 | Form 4 |
| 2025-10-02 | Lilly Endowment Inc10% owner | Sale | 101,112 | 821.09 | $83.02M | 95,040,866 | Form 4 |
| 2025-10-02 | Lilly Endowment Inc10% owner | Sale | 5,214 | 822.35 | $4.29M | 95,035,652 | Form 4 |
| 2025-10-02 | Lilly Endowment Inc10% owner | Sale | 1,540 | 823.60 | $1.27M | 95,034,112 | Form 4 |
| 2025-10-02 | Lilly Endowment Inc10% owner | Sale | 205 | 824.10 | $168,940 | 95,033,907 | Form 4 |
| 2025-10-02 | Lilly Endowment Inc10% owner | Sale | 1,715 | 826.30 | $1.42M | 95,032,192 | Form 4 |
| 2025-10-02 | Lilly Endowment Inc10% owner | Sale | 358 | 828.35 | $296,549 | 95,031,834 | Form 4 |
| 2025-10-02 | Lilly Endowment Inc10% owner | Sale | 300 | 830.20 | $249,060 | 95,031,534 | Form 4 |
| 2025-10-02 | Lilly Endowment Inc10% owner | Sale | 887 | 833.03 | $738,898 | 95,030,647 | Form 4 |
| 2025-10-02 | Lilly Endowment Inc10% owner | Sale | 1,265 | 833.92 | $1.05M | 95,029,382 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 800 | 765.75 | $612,600 | 95,492,193 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 700 | 766.93 | $536,851 | 95,491,493 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 500 | 773.43 | $386,715 | 95,490,993 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 400 | 774.98 | $309,992 | 95,490,593 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 201 | 780.28 | $156,836 | 95,490,392 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 250 | 781.65 | $195,412 | 95,490,142 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 1,136 | 783.07 | $889,568 | 95,489,006 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 2,192 | 784.13 | $1.72M | 95,486,814 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 13,845 | 785.14 | $10.87M | 95,472,969 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 9,602 | 785.89 | $7.55M | 95,463,367 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 8,259 | 786.74 | $6.50M | 95,455,108 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 3,753 | 788.28 | $2.96M | 95,451,355 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 424 | 788.97 | $334,523 | 95,450,931 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 23 | 789.57 | $18,160 | 95,450,908 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 4,167 | 791.07 | $3.30M | 95,446,741 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 9,191 | 792.07 | $7.28M | 95,437,550 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 15,934 | 793.15 | $12.64M | 95,421,616 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 5,571 | 794.17 | $4.42M | 95,416,045 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 3,248 | 795.10 | $2.58M | 95,412,797 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 2,009 | 796.59 | $1.60M | 95,410,788 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 5,494 | 797.55 | $4.38M | 95,405,294 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 4,541 | 798.65 | $3.63M | 95,400,753 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 2,499 | 799.46 | $2.00M | 95,398,254 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 5,883 | 800.88 | $4.71M | 95,392,371 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 11,401 | 801.78 | $9.14M | 95,380,970 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 9,361 | 802.64 | $7.51M | 95,371,609 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 639 | 804.36 | $513,986 | 95,370,970 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 2,394 | 805.43 | $1.93M | 95,368,576 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 4,762 | 806.23 | $3.84M | 95,363,814 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 6,014 | 807.41 | $4.86M | 95,357,800 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 5,388 | 808.33 | $4.36M | 95,352,412 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 3,233 | 809.29 | $2.62M | 95,349,179 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 2,263 | 810.58 | $1.83M | 95,346,916 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 7,226 | 811.55 | $5.86M | 95,339,690 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 18,465 | 812.42 | $15.00M | 95,321,225 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 13,770 | 813.36 | $11.20M | 95,307,455 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 14,307 | 814.53 | $11.65M | 95,293,148 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 10,847 | 815.27 | $8.84M | 95,282,301 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 4,784 | 816.62 | $3.91M | 95,277,517 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 4,137 | 817.65 | $3.38M | 95,273,380 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 2,750 | 818.76 | $2.25M | 95,270,630 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 4,315 | 819.83 | $3.54M | 95,266,315 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 3,800 | 820.76 | $3.12M | 95,262,515 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 2,400 | 822.13 | $1.97M | 95,260,115 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 6,609 | 823.37 | $5.44M | 95,253,506 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 8,090 | 824.57 | $6.67M | 95,245,416 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 18,710 | 825.39 | $15.44M | 95,226,706 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 18,986 | 826.43 | $15.69M | 95,207,720 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 14,549 | 827.56 | $12.04M | 95,193,171 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 23,151 | 828.41 | $19.18M | 95,170,020 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 14,341 | 829.36 | $11.89M | 95,155,679 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 4,868 | 830.41 | $4.04M | 95,150,811 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 2,365 | 831.30 | $1.97M | 95,148,446 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 5,668 | 832.43 | $4.72M | 95,142,778 | Form 4 |
| 2025-10-01 | Lilly Endowment Inc10% owner | Sale | 800 | 833.15 | $666,520 | 95,141,978 | Form 4 |
| 2025-09-30 | Lilly Endowment Inc10% owner | Sale | 90,501 | 763.10 | $69.06M | 95,516,186 | Form 4 |
| 2025-09-30 | Lilly Endowment Inc10% owner | Sale | 19,492 | 764.36 | $14.90M | 95,496,694 | Form 4 |
| 2025-09-30 | Lilly Endowment Inc10% owner | Sale | 2,649 | 765.44 | $2.03M | 95,494,045 | Form 4 |
| 2025-09-30 | Lilly Endowment Inc10% owner | Sale | 1,052 | 766.12 | $805,958 | 95,492,993 | Form 4 |
| 2025-09-19 | Lilly Endowment Inc10% owner | Sale | 22,965 | 763.05 | $17.52M | 95,607,387 | Form 4 |
| 2025-09-19 | Lilly Endowment Inc10% owner | Sale | 700 | 764.47 | $535,129 | 95,606,687 | Form 4 |
| 2025-09-18 | Lilly Endowment Inc10% owner | Sale | 39,863 | 763.29 | $30.43M | 95,697,115 | Form 4 |
| 2025-09-18 | Lilly Endowment Inc10% owner | Sale | 23,067 | 764.52 | $17.64M | 95,674,048 | Form 4 |
| 2025-09-18 | Lilly Endowment Inc10% owner | Sale | 26,647 | 765.57 | $20.40M | 95,647,401 | Form 4 |
| 2025-09-18 | Lilly Endowment Inc10% owner | Sale | 13,135 | 766.45 | $10.07M | 95,634,266 | Form 4 |
| 2025-09-18 | Lilly Endowment Inc10% owner | Sale | 3,914 | 767.07 | $3.00M | 95,630,352 | Form 4 |
| 2025-08-28 | Zakrowski Donald ASVP, Finance, & CAO | Saleplan | 1,000 | 734.93 | $734,930 | 3,840 | Form 4 |
| 2025-08-15 | Montarce LucasEVP & CFO | Buy | 715 | 691.79 | $494,630 | 14,685 | Form 4 |
| 2025-08-13 | Alvarez RalphDirector | Buyindirect | 758 | 660.25 | $500,470 | 758 | Form 4 |
| 2025-08-13 | Van Naarden JacobEVP & Pres., Lilly Oncology | Buy | 1,000 | 647.36 | $647,360 | 20,562 | Form 4 |
| 2025-08-12 | Fyrwald J ErikDirector | Buy | 686 | 642.00 | $440,412 | 73,699 | Form 4 |
| 2025-08-12 | Fyrwald J ErikDirector | Buy | 879 | 642.59 | $564,837 | 74,578 | Form 4 |
| 2025-08-12 | Sulzberger GabrielleDirector | Buy | 117 | 641.18 | $75,018 | 2,703 | Form 4 |
| 2025-08-12 | Skovronsky DanielEVP, CSO & Pres. LRL & LLY Imm | Buy | 1,000 | 634.41 | $634,410 | 137,660 | Form 4 |
| 2025-08-12 | Ricks David ADirector, President, Chair, and CEO | Buy | 1,632 | 644.77 | $1.05M | 546,601 | Form 4 |
| 2025-08-11 | Yuffa IlyaEVP&Pres, LLY USA&Global Capab | Saleplan | 1,250 | 627.01 | $783,762 | 26,260 | Form 4 |
| 2025-08-08 | Jackson JamereDirector | Buy | 200 | 639.56 | $127,912 | 9,402 | Form 4 |
| 2025-07-24 | Lilly Endowment Inc10% owner | Sale | 63,566 | 803.48 | $51.07M | 95,953,412 | Form 4 |
| 2025-07-24 | Lilly Endowment Inc10% owner | Sale | 102,975 | 804.48 | $82.84M | 95,850,437 | Form 4 |
| 2025-07-24 | Lilly Endowment Inc10% owner | Sale | 46,771 | 805.33 | $37.67M | 95,803,666 | Form 4 |
| 2025-07-24 | Lilly Endowment Inc10% owner | Sale | 22,138 | 806.60 | $17.86M | 95,781,528 | Form 4 |
| 2025-07-24 | Lilly Endowment Inc10% owner | Sale | 36,183 | 807.49 | $29.22M | 95,745,345 | Form 4 |
| 2025-07-24 | Lilly Endowment Inc10% owner | Sale | 8,367 | 808.34 | $6.76M | 95,736,978 | Form 4 |
| 2025-05-27 | Zakrowski Donald ASVP, Finance, & CAO | Saleplan | 1,000 | 716.41 | $716,410 | 4,840 | Form 4 |
| 2025-05-14 | Yuffa IlyaEVP & President, LLY Int'l | Saleplan | 1,250 | 749.24 | $936,550 | 27,510 | Form 4 |
| 2025-03-13 | Zakrowski Donald ASVP, Finance, & CAO | Saleplan | 1,000 | 818.24 | $818,240 | 5,840 | Form 4 |
| 2025-03-03 | Lilly Endowment Inc10% owner | Sale | 18,828 | 922.42 | $17.37M | 96,218,150 | Form 4 |
| 2025-03-03 | Lilly Endowment Inc10% owner | Sale | 8,197 | 923.25 | $7.57M | 96,209,953 | Form 4 |
| 2025-03-03 | Lilly Endowment Inc10% owner | Sale | 7,665 | 924.53 | $7.09M | 96,202,288 | Form 4 |
| 2025-03-03 | Lilly Endowment Inc10% owner | Sale | 3,691 | 925.55 | $3.42M | 96,198,597 | Form 4 |
| 2025-03-03 | Lilly Endowment Inc10% owner | Sale | 8,401 | 927.03 | $7.79M | 96,190,196 | Form 4 |
And 93 older ones, each in its filing at the SEC.
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
156 × grant or award29 × option exercise29 × shares withheld for tax11 × gift
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-21 | Fyrwald J ErikDirector | Grant or award A | +9 | 1164.89 | 75,536 | Form 4 |
| 2026-09-21 | Luciano Juan RDirector | Grant or award A | +14 | 1164.89 | 16,957 | Form 4 |
| 2026-09-21 | Sulzberger GabrielleDirector | Grant or award A | +4 | 1164.89 | 3,012 | Form 4 |
| 2026-09-21 | Alvarez RalphDirector | Grant or award A | +11 | 1164.89 | 55,838 | Form 4 |
| 2026-09-09 | Seymour MelissaEVP, Global Quality | Gift G | −12 | – | 1,038 | Form 4 |
| 2026-09-02 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Gift G | −13 | – | 46,083 | Form 4 |
| 2026-09-02 | Dozier EricEVP, Chief People Officer | Gift G | −216 | – | 14,239 | Form 4 |
| 2026-08-17 | Fyrwald J ErikDirector | Grant or award A | +8 | 1183.16 | 75,418 | Form 4 |
| 2026-08-17 | Luciano Juan RDirector | Grant or award A | +13 | 1183.16 | 16,918 | Form 4 |
| 2026-08-17 | Sulzberger GabrielleDirector | Grant or award A | +4 | 1183.16 | 3,004 | Form 4 |
| 2026-08-17 | Alvarez RalphDirector | Grant or award A | +10 | 1183.16 | 55,745 | Form 4 |
| 2026-08-01 | Seymour MelissaEVP, Global Quality | Option exercise M | +981 | – | 1,506 | Form 4 |
| 2026-08-01 | Seymour MelissaEVP, Global Quality | Shares withheld for tax F | −439 | 1148.84 | 1,067 | Form 4 |
| 2026-07-20 | Fyrwald J ErikDirector | Grant or award A | +9 | 1146.90 | 75,410 | Form 4 |
| 2026-07-20 | Luciano Juan RDirector | Grant or award A | +14 | 1146.90 | 16,905 | Form 4 |
| 2026-07-20 | Sulzberger GabrielleDirector | Grant or award A | +4 | 1146.90 | 3,000 | Form 4 |
| 2026-07-20 | Alvarez RalphDirector | Grant or award A | +11 | 1146.90 | 55,734 | Form 4 |
| 2026-06-15 | Fyrwald J ErikDirector | Grant or award A | +9 | 1129.35 | 75,401 | Form 4 |
| 2026-06-15 | Luciano Juan RDirector | Grant or award A | +14 | 1129.35 | 16,891 | Form 4 |
| 2026-06-15 | Sulzberger GabrielleDirector | Grant or award A | +4 | 1129.35 | 2,995 | Form 4 |
| 2026-06-15 | Alvarez RalphDirector | Grant or award A | +11 | 1129.35 | 55,723 | Form 4 |
| 2026-05-18 | Fyrwald J ErikDirector | Grant or award A | +10 | 988.09 | 75,280 | Form 4 |
| 2026-05-18 | Luciano Juan RDirector | Grant or award A | +16 | 988.09 | 16,851 | Form 4 |
| 2026-05-18 | Sulzberger GabrielleDirector | Grant or award A | +5 | 988.09 | 2,987 | Form 4 |
| 2026-05-18 | Alvarez RalphDirector | Grant or award A | +13 | 988.09 | 55,627 | Form 4 |
| 2026-04-20 | Alvarez RalphDirector | Grant or award A | +14 | 919.90 | 55,615 | Form 4 |
| 2026-04-20 | Fyrwald J ErikDirector | Grant or award A | +11 | 919.90 | 75,270 | Form 4 |
| 2026-04-20 | Luciano Juan RDirector | Grant or award A | +17 | 919.90 | 16,835 | Form 4 |
| 2026-04-20 | Sulzberger GabrielleDirector | Grant or award A | +5 | 919.90 | 2,982 | Form 4 |
| 2026-03-16 | Fyrwald J ErikDirector | Grant or award A | +10 | 989.12 | 75,259 | Form 4 |
| 2026-03-16 | Luciano Juan RDirector | Grant or award A | +16 | 989.12 | 16,817 | Form 4 |
| 2026-03-16 | Sulzberger GabrielleDirector | Grant or award A | +5 | 989.12 | 2,976 | Form 4 |
| 2026-03-16 | Alvarez RalphDirector | Grant or award A | +13 | 989.12 | 55,601 | Form 4 |
| 2026-02-19 | Dozier EricEVP, Chief People Officer | Gift G | −481 | – | 14,455 | Form 4 |
| 2026-02-17 | Fyrwald J ErikDirector | Grant or award A | +10 | 1036.05 | 75,120 | Form 4 |
| 2026-02-17 | Luciano Juan RDirector | Grant or award A | +15 | 1036.05 | 16,772 | Form 4 |
| 2026-02-17 | Sulzberger GabrielleDirector | Grant or award A | +5 | 1036.05 | 2,966 | Form 4 |
| 2026-02-17 | Alvarez RalphDirector | Grant or award A | +12 | 1036.05 | 55,492 | Form 4 |
| 2026-02-16 | Zakrowski Donald ASVP, Finance, & CAO | Option exercise M | +184 | – | 3,607 | Form 4 |
| 2026-02-16 | Zakrowski Donald ASVP, Finance, & CAO | Shares withheld for tax F | −82 | 1040.00 | 3,526 | Form 4 |
| 2026-02-16 | Montarce LucasEVP & CFO | Option exercise M | +368 | – | 16,418 | Form 4 |
| 2026-02-16 | Montarce LucasEVP & CFO | Shares withheld for tax F | −160 | 1040.00 | 16,258 | Form 4 |
| 2026-02-16 | Custer Kenneth L.EVP & President, Card Met Hlth | Option exercise M | +207 | – | 10,232 | Form 4 |
| 2026-02-16 | Custer Kenneth L.EVP & President, Card Met Hlth | Shares withheld for tax F | −91 | 1040.00 | 10,141 | Form 4 |
| 2026-02-16 | Brown Adrienne SEVP, President LLY Imm | Option exercise M | +391 | – | 5,312 | Form 4 |
| 2026-02-16 | Brown Adrienne SEVP, President LLY Imm | Shares withheld for tax F | −170 | 1040.00 | 5,142 | Form 4 |
| 2026-02-09 | Rau DiogoEVP & CIDO | Grant or award A | +4,599 | 1044.67 | 26,397 | Form 4/A |
| 2026-02-09 | Ricks David ADirector, President, Chair, and CEO | Grant or award A | +38,914 | 1044.67 | 571,715 | Form 4 |
| 2026-02-09 | Zakrowski Donald ASVP, Finance, & CAO | Grant or award A | +584 | 1044.67 | 3,423 | Form 4 |
| 2026-02-09 | Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD | Grant or award A | +4,866 | 1044.67 | 26,626 | Form 4 |
| 2026-02-09 | Hakim AnatEVP, GC & Secretary | Grant or award A | +8,278 | 1044.67 | 22,987 | Form 4 |
| 2026-02-09 | Skovronsky DanielEVP, CS&PO & Pres. LRL | Grant or award A | +15,548 | 1044.67 | 160,072 | Form 4 |
| 2026-02-09 | Montarce LucasEVP & CFO | Grant or award A | +1,365 | 1044.67 | 16,050 | Form 4 |
| 2026-02-09 | Jonsson PatrikEVP & President, LLY Int'l | Grant or award A | +4,818 | 1044.67 | 60,647 | Form 4 |
| 2026-02-09 | Yuffa IlyaEVP&Pres, LLY USA&Global Capab | Grant or award A | +4,162 | 1044.67 | 32,304 | Form 4 |
| 2026-02-09 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Grant or award A | +4,384 | 1044.67 | 46,096 | Form 4 |
| 2026-02-09 | Dozier EricEVP, Chief People Officer | Grant or award A | +3,512 | 1044.67 | 14,936 | Form 4 |
| 2026-02-09 | Custer Kenneth L.EVP & President, Card Met Hlth | Grant or award A | +659 | 1044.67 | 10,025 | Form 4 |
| 2026-02-09 | Brown Adrienne SEVP, President LLY Imm | Grant or award A | +1,196 | 1044.67 | 4,921 | Form 4 |
| 2026-02-01 | Ricks David ADirector, President, Chair, and CEO | Option exercise M | +31,932 | – | 547,098 | Form 4 |
| 2026-02-01 | Ricks David ADirector, President, Chair, and CEO | Shares withheld for tax F | −14,297 | 1037.15 | 532,802 | Form 4 |
| 2026-02-01 | Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD | Option exercise M | +4,108 | – | 24,670 | Form 4 |
| 2026-02-01 | Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD | Shares withheld for tax F | −1,909 | 1037.15 | 22,761 | Form 4 |
| 2026-02-01 | Hakim AnatEVP, GC & Secretary | Option exercise M | +6,700 | – | 17,662 | Form 4 |
| 2026-02-01 | Hakim AnatEVP, GC & Secretary | Shares withheld for tax F | −2,953 | 1037.15 | 14,709 | Form 4 |
| 2026-02-01 | Skovronsky DanielEVP, CS&PO & Pres. LRL | Option exercise M | +12,684 | – | 150,165 | Form 4 |
| 2026-02-01 | Skovronsky DanielEVP, CS&PO & Pres. LRL | Shares withheld for tax F | −5,641 | 1037.15 | 144,524 | Form 4 |
| 2026-02-01 | Jonsson PatrikEVP & President, LLY Int'l | Option exercise M | +3,930 | – | 57,581 | Form 4 |
| 2026-02-01 | Jonsson PatrikEVP & President, LLY Int'l | Shares withheld for tax F | −1,752 | 1037.15 | 55,829 | Form 4 |
| 2026-02-01 | Yuffa IlyaEVP&Pres, LLY USA&Global Capab | Option exercise M | +3,394 | – | 29,654 | Form 4 |
| 2026-02-01 | Yuffa IlyaEVP&Pres, LLY USA&Global Capab | Shares withheld for tax F | −1,512 | 1037.15 | 28,142 | Form 4 |
| 2026-02-01 | Rau DiogoEVP & CIDO | Option exercise M | +3,752 | – | 23,471 | Form 4 |
| 2026-02-01 | Rau DiogoEVP & CIDO | Shares withheld for tax F | −1,674 | 1037.15 | 21,797 | Form 4 |
| 2026-02-01 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Option exercise M | +3,572 | – | 43,303 | Form 4 |
| 2026-02-01 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Shares withheld for tax F | −1,591 | 1037.15 | 41,712 | Form 4 |
| 2026-02-01 | Dozier EricEVP, Chief People Officer | Option exercise M | +2,858 | – | 12,697 | Form 4 |
| 2026-02-01 | Dozier EricEVP, Chief People Officer | Shares withheld for tax F | −1,273 | 1037.15 | 11,424 | Form 4 |
| 2026-01-20 | Fyrwald J ErikDirector | Grant or award A | +10 | 1041.29 | 75,111 | Form 4 |
| 2026-01-20 | Luciano Juan RDirector | Grant or award A | +15 | 1041.29 | 16,757 | Form 4 |
| 2026-01-20 | Sulzberger GabrielleDirector | Grant or award A | +5 | 1041.29 | 2,961 | Form 4 |
| 2026-01-20 | Alvarez RalphDirector | Grant or award A | +12 | 1041.29 | 55,480 | Form 4 |
| 2025-12-15 | Fyrwald J ErikDirector | Grant or award A | +9 | 1062.19 | 75,101 | Form 4 |
| 2025-12-15 | Luciano Juan RDirector | Grant or award A | +14 | 1062.19 | 16,741 | Form 4 |
| 2025-12-15 | Sulzberger GabrielleDirector | Grant or award A | +5 | 1062.19 | 2,957 | Form 4 |
| 2025-12-15 | Alvarez RalphDirector | Grant or award A | +11 | 1062.19 | 55,468 | Form 4 |
| 2025-12-15 | Hedley Mary LynneDirector | Grant or award A | +9 | 1062.19 | 2,253 | Form 4 |
| 2025-11-17 | Fyrwald J ErikDirector | Grant or award A | +10 | 1021.70 | 74,773 | Form 4 |
| 2025-11-17 | Fyrwald J ErikDirector | Grant or award A | +215 | 1021.70 | 74,989 | Form 4 |
| 2025-11-17 | Jackson JamereDirector | Grant or award A | +215 | 1021.70 | 9,635 | Form 4 |
| 2025-11-17 | Luciano Juan RDirector | Grant or award A | +15 | 1021.70 | 16,489 | Form 4 |
| 2025-11-17 | Luciano Juan RDirector | Grant or award A | +215 | 1021.70 | 16,704 | Form 4 |
| 2025-11-17 | Moeller Jon RDirector | Grant or award A | +233 | 1021.70 | 304 | Form 4 |
| 2025-11-17 | Johnson Kimberly HDirector | Grant or award A | +215 | 1021.70 | 3,265 | Form 4 |
| 2025-11-17 | Sulzberger GabrielleDirector | Grant or award A | +5 | 1021.70 | 2,733 | Form 4 |
| 2025-11-17 | Sulzberger GabrielleDirector | Grant or award A | +215 | 1021.70 | 2,948 | Form 4 |
| 2025-11-17 | Alvarez RalphDirector | Grant or award A | +12 | 1021.70 | 55,163 | Form 4 |
| 2025-11-17 | Alvarez RalphDirector | Grant or award A | +215 | 1021.70 | 55,379 | Form 4 |
| 2025-11-17 | Hedley Mary LynneDirector | Grant or award A | +10 | 1021.70 | 2,026 | Form 4 |
| 2025-11-17 | Hedley Mary LynneDirector | Grant or award A | +215 | 1021.70 | 2,241 | Form 4 |
| 2025-11-17 | Baicker KatherineDirector | Grant or award A | +215 | 1021.70 | 23,503 | Form 4 |
| 2025-11-17 | Kaelin William G JrDirector | Grant or award A | +215 | 1021.70 | 21,837 | Form 4 |
| 2025-11-10 | Ricks David ADirector, President, Chair, and CEO | Gift G | −24,750 | – | 515,166 | Form 4 |
| 2025-11-10 | Skovronsky DanielEVP, CS&PO & Pres. LRL | Gift G | −179 | – | 137,481 | Form 4 |
| 2025-10-20 | Fyrwald J ErikDirector | Grant or award A | +12 | 808.96 | 74,764 | Form 4 |
| 2025-10-20 | Luciano Juan RDirector | Grant or award A | +18 | 808.96 | 16,474 | Form 4 |
| 2025-10-20 | Sulzberger GabrielleDirector | Grant or award A | +6 | 808.96 | 2,728 | Form 4 |
| 2025-10-20 | Alvarez RalphDirector | Grant or award A | +15 | 808.96 | 55,152 | Form 4 |
| 2025-10-20 | Hedley Mary LynneDirector | Grant or award A | +12 | 808.96 | 2,016 | Form 4 |
| 2025-09-22 | Seymour MelissaEVP, Global Quality | Gift G | −17 | – | 1,050 | Form 4 |
| 2025-09-15 | Fyrwald J ErikDirector | Grant or award A | +13 | 748.19 | 74,751 | Form 4 |
| 2025-09-15 | Luciano Juan RDirector | Grant or award A | +20 | 748.19 | 16,456 | Form 4 |
| 2025-09-15 | Sulzberger GabrielleDirector | Grant or award A | +7 | 748.19 | 2,722 | Form 4 |
| 2025-09-15 | Alvarez RalphDirector | Grant or award A | +16 | 748.19 | 55,138 | Form 4 |
| 2025-09-15 | Hedley Mary LynneDirector | Grant or award A | +13 | 748.19 | 2,003 | Form 4 |
| 2025-09-05 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Gift G | −17 | – | 39,731 | Form 4 |
| 2025-08-18 | Alvarez RalphDirector | Grant or award A | +17 | 698.05 | 55,011 | Form 4 |
| 2025-08-18 | Fyrwald J ErikDirector | Grant or award A | +14 | 698.05 | 74,592 | Form 4 |
| 2025-08-18 | Hedley Mary LynneDirector | Grant or award A | +14 | 698.05 | 1,987 | Form 4 |
| 2025-08-18 | Luciano Juan RDirector | Grant or award A | +21 | 698.05 | 16,403 | Form 4 |
| 2025-08-18 | Sulzberger GabrielleDirector | Grant or award A | +7 | 698.05 | 2,710 | Form 4 |
| 2025-08-01 | Seymour MelissaEVP, Global Quality | Option exercise M | +952 | – | 952 | Form 4 |
| 2025-08-01 | Seymour MelissaEVP, Global Quality | Shares withheld for tax F | −427 | 740.07 | 525 | Form 4 |
| 2025-07-21 | Alvarez RalphDirector | Grant or award A | +15 | 762.18 | 54,995 | Form 4 |
| 2025-07-21 | Fyrwald J ErikDirector | Grant or award A | +13 | 762.18 | 73,013 | Form 4 |
| 2025-07-21 | Hedley Mary LynneDirector | Grant or award A | +13 | 762.18 | 1,973 | Form 4 |
| 2025-07-21 | Sulzberger GabrielleDirector | Grant or award A | +7 | 762.18 | 2,586 | Form 4 |
| 2025-07-21 | Luciano Juan RDirector | Grant or award A | +19 | 762.18 | 16,382 | Form 4 |
| 2025-06-16 | Alvarez RalphDirector | Grant or award A | +15 | 807.58 | 54,979 | Form 4 |
| 2025-06-16 | Fyrwald J ErikDirector | Grant or award A | +12 | 807.58 | 73,000 | Form 4 |
| 2025-06-16 | Hedley Mary LynneDirector | Grant or award A | +12 | 807.58 | 1,960 | Form 4 |
| 2025-06-16 | Luciano Juan RDirector | Grant or award A | +18 | 807.58 | 16,362 | Form 4 |
| 2025-06-16 | Sulzberger GabrielleDirector | Grant or award A | +6 | 807.58 | 2,580 | Form 4 |
| 2025-05-19 | Alvarez RalphDirector | Grant or award A | +16 | 755.11 | 54,863 | Form 4 |
| 2025-05-19 | Fyrwald J ErikDirector | Grant or award A | +13 | 755.11 | 72,852 | Form 4 |
| 2025-05-19 | Hedley Mary LynneDirector | Grant or award A | +13 | 755.11 | 1,944 | Form 4 |
| 2025-05-19 | Luciano Juan RDirector | Grant or award A | +20 | 755.11 | 16,314 | Form 4 |
| 2025-05-19 | Sulzberger GabrielleDirector | Grant or award A | +7 | 755.11 | 2,569 | Form 4 |
| 2025-05-02 | Hakim AnatEVP, GC & Secretary | Gift G | −17,875 | – | 10,962 | Form 4 |
| 2025-04-21 | Alvarez RalphDirector | Grant or award A | +14 | 818.02 | 54,847 | Form 4 |
| 2025-04-21 | Fyrwald J ErikDirector | Grant or award A | +12 | 818.02 | 72,839 | Form 4 |
| 2025-04-21 | Hedley Mary LynneDirector | Grant or award A | +12 | 818.02 | 1,931 | Form 4 |
| 2025-04-21 | Luciano Juan RDirector | Grant or award A | +18 | 818.02 | 16,294 | Form 4 |
| 2025-04-21 | Sulzberger GabrielleDirector | Grant or award A | +6 | 818.02 | 2,562 | Form 4 |
| 2025-03-17 | Alvarez RalphDirector | Grant or award A | +14 | 824.76 | 54,833 | Form 4 |
| 2025-03-17 | Fyrwald J ErikDirector | Grant or award A | +12 | 824.76 | 72,827 | Form 4 |
| 2025-03-17 | Hedley Mary LynneDirector | Grant or award A | +12 | 824.76 | 1,919 | Form 4 |
| 2025-03-17 | Luciano Juan RDirector | Grant or award A | +18 | 824.76 | 16,276 | Form 4 |
| 2025-03-17 | Sulzberger GabrielleDirector | Grant or award A | +6 | 824.76 | 2,556 | Form 4 |
| 2025-03-01 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Option exercise M | +2,837 | – | 41,009 | Form 4 |
| 2025-03-01 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Shares withheld for tax F | −1,260 | 920.63 | 39,748 | Form 4 |
| 2025-03-01 | Dozier EricEVP, Chief People Officer | Option exercise M | +2,403 | – | 10,905 | Form 4 |
| 2025-03-01 | Dozier EricEVP, Chief People Officer | Shares withheld for tax F | −1,066 | 920.63 | 9,839 | Form 4 |
| 2025-02-20 | Dozier EricEVP, Chief People Officer | Gift G | −460 | – | 8,502 | Form 4 |
| 2025-02-18 | Alvarez RalphDirector | Grant or award A | +14 | 857.20 | 54,719 | Form 4 |
| 2025-02-18 | Fyrwald J ErikDirector | Grant or award A | +12 | 857.20 | 72,683 | Form 4 |
| 2025-02-18 | Hedley Mary LynneDirector | Grant or award A | +12 | 857.20 | 1,904 | Form 4 |
| 2025-02-18 | Luciano Juan RDirector | Grant or award A | +17 | 857.20 | 16,229 | Form 4 |
| 2025-02-18 | Sulzberger GabrielleDirector | Grant or award A | +6 | 857.20 | 2,545 | Form 4 |
| 2025-02-10 | Skovronsky DanielEVP, CSO & Pres. LRL & LLY Imm | Grant or award A | +18,772 | 868.88 | 136,660 | Form 4 |
| 2025-02-10 | Hakim AnatEVP, GC & Secretary | Grant or award A | +10,321 | 868.88 | 28,838 | Form 4 |
| 2025-02-10 | Ricks David ADirector, President, Chair, and CEO | Grant or award A | +55,132 | 868.88 | 539,613 | Form 4 |
| 2025-02-10 | Dozier EricEVP, HR & Diversity | Grant or award A | +920 | 868.88 | 8,962 | Form 4 |
| 2025-02-10 | Zakrowski Donald ASVP, Finance, & CAO | Grant or award A | +1,360 | 868.88 | 6,840 | Form 4 |
| 2025-02-10 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Grant or award A | +5,974 | 868.88 | 38,172 | Form 4 |
| 2025-02-10 | Jonsson PatrikEVP&Pres, CardMetHlth, LLY USA | Grant or award A | +7,170 | 868.88 | 53,651 | Form 4 |
| 2025-02-10 | Montarce LucasEVP & CFO | Grant or award A | +2,896 | 868.88 | 13,970 | Form 4 |
| 2025-02-10 | Rau DiogoEVP & CIDO | Grant or award A | +6,815 | 868.88 | 19,719 | Form 4 |
| 2025-02-10 | Van Naarden JacobEVP & Pres., Lilly Oncology | Grant or award A | +6,104 | 868.88 | 19,562 | Form 4 |
| 2025-02-10 | White Anne E.EVP & Pres, Lilly Neuroscience | Grant or award A | +6,829 | 868.88 | 74,210 | Form 4 |
| 2025-02-10 | Yuffa IlyaEVP & President, LLY Int'l | Grant or award A | +7,123 | 868.88 | 28,760 | Form 4 |
| 2025-02-01 | Hakim AnatEVP, GC & Secretary | Option exercise M | +4,904 | – | 20,683 | Form 4 |
| 2025-02-01 | Hakim AnatEVP, GC & Secretary | Shares withheld for tax F | −2,166 | 811.08 | 18,517 | Form 4 |
| 2025-02-01 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Option exercise M | +2,861 | – | 33,479 | Form 4 |
| 2025-02-01 | Hernandez EdgardoEVP & Pres., Mfg. Operations | Shares withheld for tax F | −1,282 | 811.08 | 32,198 | Form 4 |
| 2025-02-01 | Jonsson PatrikEVP&Pres, CardMetHlth, LLY USA | Option exercise M | +3,433 | – | 48,016 | Form 4 |
| 2025-02-01 | Jonsson PatrikEVP&Pres, CardMetHlth, LLY USA | Shares withheld for tax F | −1,536 | 811.08 | 46,480 | Form 4 |
| 2025-02-01 | Rau DiogoEVP & CIDO | Option exercise M | +3,269 | – | 14,370 | Form 4 |
| 2025-02-01 | Rau DiogoEVP & CIDO | Shares withheld for tax F | −1,466 | 811.08 | 12,904 | Form 4 |
| 2025-02-01 | Ricks David ADirector, President, Chair, and CEO | Option exercise M | +26,561 | – | 496,385 | Form 4 |
| 2025-02-01 | Ricks David ADirector, President, Chair, and CEO | Shares withheld for tax F | −11,903 | 811.08 | 484,482 | Form 4 |
| 2025-02-01 | Skovronsky DanielEVP, CSO & Pres. LRL & LLY Imm | Option exercise M | +8,989 | – | 126,892 | Form 4 |
| 2025-02-01 | Skovronsky DanielEVP, CSO & Pres. LRL & LLY Imm | Shares withheld for tax F | −4,004 | 811.08 | 122,888 | Form 4 |
| 2025-02-01 | Van Naarden JacobEVP & Pres., Lilly Oncology | Option exercise M | +3,023 | – | 14,868 | Form 4 |
| 2025-02-01 | Van Naarden JacobEVP & Pres., Lilly Oncology | Shares withheld for tax F | −1,410 | 811.08 | 13,458 | Form 4 |
| 2025-02-01 | White Anne E.EVP & Pres, Lilly Neuroscience | Option exercise M | +3,269 | – | 68,838 | Form 4 |
| 2025-02-01 | White Anne E.EVP & Pres, Lilly Neuroscience | Shares withheld for tax F | −1,457 | 811.08 | 67,381 | Form 4 |
| 2025-02-01 | Yuffa IlyaEVP & President, LLY Int'l | Option exercise M | +3,269 | – | 23,071 | Form 4 |
| 2025-02-01 | Yuffa IlyaEVP & President, LLY Int'l | Shares withheld for tax F | −1,434 | 811.08 | 21,637 | Form 4 |
| 2025-01-21 | Alvarez RalphDirector | Grant or award A | +16 | 742.35 | 54,705 | Form 4 |
| 2025-01-21 | Fyrwald J ErikDirector | Grant or award A | +13 | 742.35 | 72,672 | Form 4 |
| 2025-01-21 | Hedley Mary LynneDirector | Grant or award A | +13 | 742.35 | 1,892 | Form 4 |
| 2025-01-21 | Luciano Juan RDirector | Grant or award A | +20 | 742.35 | 16,211 | Form 4 |
| 2025-01-21 | Sulzberger GabrielleDirector | Grant or award A | +7 | 742.35 | 2,540 | Form 4 |
| 2024-12-16 | Alvarez RalphDirector | Grant or award A | +15 | 779.00 | 54,690 | Form 4 |
| 2024-12-16 | Hedley Mary LynneDirector | Grant or award A | +13 | 779.00 | 1,879 | Form 4 |
| 2024-12-16 | Johnson Kimberly HDirector | Grant or award A | +12 | 779.00 | 3,032 | Form 4 |
| 2024-12-16 | Luciano Juan RDirector | Grant or award A | +19 | 779.00 | 16,191 | Form 4 |
| 2024-12-16 | Sulzberger GabrielleDirector | Grant or award A | +13 | 779.00 | 2,533 | Form 4 |
| 2024-11-18 | Alvarez RalphDirector | Grant or award A | +16 | 727.20 | 54,284 | Form 4 |
| 2024-11-18 | Alvarez RalphDirector | Grant or award A | +303 | 727.20 | 54,586 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.